Active Ingredient History
Carbon monoxide-releasing molecules (CORMs) are chemical compounds designed to release controlled amounts of carbon monoxide (CO). CORMs are being developed as potential therapeutic agents to locally deliver CO to cells and tissues, thus overcoming limitations of CO gas inhalation protocols. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Anemia (Phase 1)
Anemia, Sickle Cell (Phase 2)
Blood Loss, Surgical (Phase 2)
Brain Ischemia (Phase 2)
Chronic Limb-Threatening Ischemia (Phase 2)
General Surgery (Phase 2)
Hemoglobin SC Disease (Phase 2)
Hypotension (Phase 3)
Hypoxia (Phase 1/Phase 2)
Ischemia (Phase 3)
Ischemic Stroke (Phase 1)
Kidney Transplantation (Phase 2/Phase 3)
Leg Ulcer (Phase 2)
Prostatic Neoplasms (Phase 2)
Renal Insufficiency, Chronic (Phase 1)
Vascular Diseases (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue